Search Results 1761-1770 of 16340 for Chiari malformation

1. My First Mayo Moments

   In the wake of thoracic outlet syndrome, an outdoors enthusiast triumphs · About the News Network · Newsbureau@mayo.edu · News Releases · Cancer ...

2. Overview - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

   ... syndrome, familial hypercholesterolemia, and atrial fibrillation. The GIRA results report will also be sent to clinicians as an in-basket message and will ...

3. A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC) - Mayo Clinic

   Clinically significant gastrointestinal abnormalities that may increase ... Malabsorption syndrome;; Any prior major resection of the stomach or small ...

4. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients - Mayo Clinic

   Participation eligibility · Meets 2017 McDonald criteria for relapsing-remitting MS [patients with clinically isolated syndrome (CIS) are not eligible]. · Must be ...

5. Neurosciences Clinical Trials - Medical Professionals

   This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). ... abnormalities in ALS we aim to ...

6. Arthritis - Doctors and departments - Mayo Clinic

   ... syndrome, Articular cartilage injury, Biceps tear, Broken elbow, Elbow impingement. Show more areas of focus for Shawn W. O'Driscoll, M.D., Ph.D.

7. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

   ... syndrome; Hodgkin Disease; Primary effusion lymphoma; Adult T-cell leukemia/lymphoma; Extranodal NK/T-cell lymphoma, nasal type; Enteropathy-type T-cell ...

8. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   Evidence of compression syndrome (e.g., ureteral, orbital ... abnormalities; No serious medical or psychiatric illness likely to interfere ...

9. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... Syndrome; Aspartate transaminase (AST) =< 2.5 x ULN; Creatinine =< 2.0 mg/dL; Calculated creatinine clearance must be >= 45 ml/min using the Cockcroft-Gault ...

10. Immune Dysfunction in Autoimmune Disease - Mayo Clinic

    ... abnormalities in other autoimmune diseases. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...